Table
1: Clinicopathological
characteristics of patients with rectal adenocarcinoma and their
correlations with MTSS1 expression.
|
Characteristics |
Number of cases (%) |
MTSS1 expression (%) |
P value |
|
|
Low or no expression |
High expression |
|
||
|
Age (years, median 59 years) |
|
|
|
P=0.528 |
|
＜median |
88(48.9) |
61(50.8) |
27(45) |
|
|
≥median |
92(51.1) |
59(49.2) |
33(55) |
|
|
Gender |
|
|
|
P=0.749 |
|
Male |
104(57.8) |
68(56.7) |
36(43.3) |
|
|
Female |
76(42.2) |
52(60.0) |
24(40.0) |
|
|
Pathologic differentiation |
|
|
|
P=0.255 |
|
Well |
10(5.6) |
7(5.8) |
3(5.0) |
|
|
Moderately |
148(82.2) |
95(79.2) |
53(88.3) |
|
|
Poorly |
22(12.2) |
18(15) |
4(6.7) |
|
|
T stage |
|
|
|
P<0.001 |
|
T 1 |
5(2.7) |
0(0) |
5(8.4) |
|
|
T 2 |
46 (25.6) |
19(15.8) |
27(45.0) |
|
|
T 3 |
46(25.6) |
35(29.2) |
11(18.3) |
|
|
T 4 |
83(46.1) |
66(55.0) |
17(28.3) |
|
|
N stage |
|
|
|
P=0.002 |
|
N0 |
91(50.6) |
50(41.7) |
41(68.3) |
|
|
N1 |
54(330) |
48(40.0) |
6(10.0) |
|
|
N2 |
35(19.4) |
22(18.3) |
13(21.7) |
|
|
M stage |
|
|
|
P=0.275 |
|
M0 |
171(95) |
112 (93.3) |
59(98.3) |
|
|
M1 |
9(5) |
8(6.7) |
1(1.7) |
|
|
Dukes stage |
|
|
|
P<0.001 |
|
A |
37(15.0) |
8(6.7) |
29(48.30) |
|
|
B |
50(16.4) |
38(31.7) |
12(20.0) |
|
|
C |
84(68.6) |
66(55.0) |
18(30.0) |
|
|
D |
9(76.4) |
8(6.7) |
1(1.7) |
|
|
UICC stage |
|
|
|
P<0.001 |
|
I |
37 (20.6) |
8(6.7) |
29(48.3) |
|
|
II |
50(27.8) |
38(31.7) |
12(20.0) |
|
|
III |
84(46.7) |
66(59.2) |
18(30.0) |
|
|
IV |
9(5) |
8(6.7) |
1(1.7) |
|
|
Surgical method |
|
|
|
P=0.134 |
|
Harfmann's |
8(4.4) |
7(5.8) |
1(1.7) |
|
|
Miles' |
41(22.8) |
31(25.8) |
10(16.7) |
|
|
Dixon's |
131(72.8) |
82(68.3) |
49(81.7) |
|
|
Recurrence |
|
|
|
P<0.001 |
|
No |
141(78.3) |
82(68.3) |
59(98.3) |
|
|
Yes |
39(21.7) |
38(37.1) |
1(1.7) |
|
|
Vital status (at follow-up) |
|
|
|
P<0.001 |
|
Alive |
114(63.3) |
59(49.2) |
55(91.7) |
|
|
Dead |
66(36.7) |
61(50.8) |
5(8.3) |
|